| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.4M | +27.5% | -5.7% |
| Cost of Revenue | $1.6M | +16.2% | -8.4% |
| Gross Profit | $1.8M | +39.2% | -3.1% |
| R&D Expense | $4.0M | -10.9% | -31.0% |
| SG&A Expense | $4.2M | +7.6% | -7.9% |
| Operating Income | -$8.9M | +7.0% | +18.6% |
| Pre-tax Income | -$11.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $21.6M | -15.2% | -52.9% |
| Accounts Receivable | $4.9M | -3.4% | -28.1% |
| Inventory | $5.8M | +19.6% | -17.1% |
| Current Assets | $36.9M | -8.0% | -42.4% |
| Total Assets | $41.5M | -8.2% | -40.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.7M | — | — |
| Capital Expenditures | $1.1M | — | — |
| Investing Cash Flow | -$1.1M | — | — |
| Financing Cash Flow | $8.2M | — | — |
| Free Cash Flow | -$23.9M | — | — |
| -19.4% |
| -6.7% |
| Income Tax | $0 | — | — |
| Net Income | -$11.0M | -19.4% | -6.7% |
| EPS (Basic) | -$0.14 | -16.7% | +0.0% |
| EPS (Diluted) | -$0.14 | -16.7% | +0.0% |
| $10.2M |
| +27.3% |
| +2.1% |
| Total Liabilities | $14.6M | +44.8% | +32.3% |
| Stockholders' Equity | $26.9M | -23.5% | -53.9% |